A research database known as SECURE-IBD provides a quick and robust source of information to clinicians around the world about the use of IBD therapies like corticosteroids and the widely prescribed tumor necrosis factor (TNF) antagonists during the COVID-19 pandemic.
In the early days of the pandemic, some of the greatest uncertainties loomed over patients with inflammatory bowel disease (IBD) who wanted reassurance that their medications did not increase the risk of infection.